Non-steroidal Anti-inflammatory Drugs Market Demand, Size, Analysis and Future Opportunities 2034
Non-steroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that are commonly used to lower fever, relieve pain, and reduce inflammation. They are commonly prescribed for conditions such as arthritis, muscle pain, menstrual cramps, and other inflammatory disorders. Unlike corticosteroids, NSAIDs do not contain steroids and work primarily by inhibiting enzymes involved in the production of prostaglandins, which are responsible for inflammation and pain. Available in both prescription and over-the-counter forms, NSAIDs come in various formats including tablets, capsules, creams, and injections. The global NSAIDs market plays a significant role in healthcare due to their broad therapeutic applications and widespread use in pain management.
According to SPER Market Research, “Global Non-steroidal Anti-inflammatory Drugs Market Growth, Size, Trends Analysis – By Disease Indication, By Route of Administration, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2034” states that Global Non-Steroidal Anti-Inflammatory Drugs Market is estimated to reach USD 40.44 million by 2034 with a CAGR of 5.92%.
Drivers:
One of the main factors propelling the market expansion for non-steroidal anti-inflammatory medications is the rising incidence of disorders that cause pain and inflammation. The use of these medications to treat both acute and chronic pain is steadily increasing. The most often recommended medications for mild to severe pain are NSAIDs and opioids. Opioid use is linked to serious side effects, though. Because of the rising number of deaths linked to opioids, opioid safety is still a big topic that is garnering a lot of attention. This has consequently resulted in a decrease in the use of opioids and a growing preference for these medications to manage pain.
Request a Free Sample Report: https://www.sperresearch.com/report-store/non-steroidal-anti-inflammatory-drugs-market.aspx?sample=1
Restraints:
The growth of the global NSAIDs market may be limited due to adverse effects associated with their use, such as allergic reactions, stomach ulcers, abdominal pain, dizziness, and other complications. While these drugs are commonly prescribed for their anti-inflammatory properties and are easily accessible, there has been a significant rise in NSAID-related gastrointestinal (GI) issues globally. This includes conditions like ulcers and GI bleeding, which have become a major cause of emergency hospital admissions. Such health risks can burden healthcare systems and may reduce patient and physician preference for NSAIDs. As a result, the overall market revenue for NSAIDs is expected to be negatively impacted.
United States of America owns the biggest revenue share in Global Non-Steroidal Anti-Inflammatory Drugs Market. It has largest market share, driven by factors such as well-established healthcare infrastructure, high prevalence of chronic pain conditions, and the presence of major pharmaceutical companies. Some key market players are Pfizer Inc, Bayer AG, GSK plc, Dr. Reddys Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd.
For More Information, refer to below link: –
Non-steroidal Anti-inflammatory Drugs Market Growth
Related Reports:
Global Astaxanthin Market Size
Global GI Stool Testing Market Growth
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant — USA
SPER Market Research
enquiries@sperresearch.com
+1–347–460–2899
